25.02.2025 • News

Symrise and Hofseth BioCare Partner on Marine Ingredients

German flavor and fragrance company Symrise has signed a strategic partnership with Hofseth BioCare (HBC), a Norwegian manufacturer of salmon-based ingredients for the human health and pet nutrition markets. With this partnership, Symrise wants to expand its presence in the health sector with clinically proven marine ingredients, the company said.

To support its growth plans, HBC intends to convert its facility in Berkak into a state-of-the-art enzymatic hydrolysis plant that will triple the company’s current production.

“This partnership with HBC is testament to their unique footprint and differentiated science. Their investments in clinical studies demonstrate proven benefits in key categories of metabolic health, immune health, gut health and mobility, setting them apart. This partnership is well aligned with our willingness to accelerate in health in the context of our “One Care“ journey but also with the recent creation of the Global Marine Platform to explore the vast potential that the oceans could offer us,” said Jean-Yves Parisot, CEO of Symrise.

HBC has developed a proprietary technology to upcycle fresh salmon offcuts not used in the production of fillets into bioactive ingredients with demonstrated health benefits.

Jon Olav Odegard, CEO of HBC, commented: “The human health and premium pet markets continue to grow very strongly, and this partnership will allow us to sustain our growth trajectory and position us as the leading player in the science-led marine nutrition segment dedicated to human health.”

Source: Symrise
Source: Symrise

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read